New Zealand - English - Medsafe (Medicines Safety Authority)

morgan and hall ltd - dibasic sodium phosphate 0.018%{relative}; disodium edetate dihydrate 0.01%{relative}; monobasic sodium phosphate dihydrate 0.33%{relative}; sodium chloride 0.827%{relative}; thiomersal 0.002%{relative} - contact lens solution - active: dibasic sodium phosphate 0.018%{relative} disodium edetate dihydrate 0.01%{relative} monobasic sodium phosphate dihydrate 0.33%{relative} sodium chloride 0.827%{relative} thiomersal 0.002%{relative}

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - edetate disodium (unii: 7fld91c86k) (edetic acid - unii:9g34hu7rv0) -

United States - English - NLM (National Library of Medicine)

evereen shanghai biotechnology ltd. - edetate disodium (unii: 7fld91c86k) (edetic acid - unii:9g34hu7rv0) -

New Zealand - English - Medsafe (Medicines Safety Authority)

smith & nephew ltd - benzalkonium chloride 0.004%{relative} (0.008% as 50% solution); disodium edetate dihydrate 0.02%{relative};  ; polyvinyl alcohol 1.4%{relative} - eye drops, solution - 0.004%/0.02%/1.4% - active: benzalkonium chloride 0.004%{relative} (0.008% as 50% solution) disodium edetate dihydrate 0.02%{relative}   polyvinyl alcohol 1.4%{relative} excipient: hyetellose purified water sodium chloride sodium hydroxide

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trisodium caloxetate; trometamol; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trometamol; sodium hydroxide; hydrochloric acid; water for injections; trisodium caloxetate - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; trisodium caloxetate; water for injections; sodium hydroxide; trometamol - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trisodium caloxetate; sodium hydroxide; trometamol; water for injections; hydrochloric acid - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; trisodium caloxetate; trometamol; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; trisodium caloxetate; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion